124 related articles for article (PubMed ID: 37392050)
41. Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma.
Zheng W; Lin Q; Issah MA; Liao Z; Shen J
BMC Cancer; 2021 Aug; 21(1):927. PubMed ID: 34404374
[TBL] [Abstract][Full Text] [Related]
42. Screening Biomarkers for Systemic Lupus Erythematosus Based on Machine Learning and Exploring Their Expression Correlations With the Ratios of Various Immune Cells.
Zhong Y; Zhang W; Hong X; Zeng Z; Chen Y; Liao S; Cai W; Xu Y; Wang G; Liu D; Tang D; Dai Y
Front Immunol; 2022; 13():873787. PubMed ID: 35757721
[TBL] [Abstract][Full Text] [Related]
43. Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling.
Rizzello C; Cancila V; Sangaletti S; Botti L; Ratti C; Milani M; Dugo M; Bertoni F; Tripodo C; Chiodoni C; Colombo MP
Mol Cancer; 2022 Dec; 21(1):215. PubMed ID: 36503430
[TBL] [Abstract][Full Text] [Related]
44. Association of Abnormal Elevations in IFIT3 With Overactive Cyclic GMP-AMP Synthase/Stimulator of Interferon Genes Signaling in Human Systemic Lupus Erythematosus Monocytes.
Wang J; Dai M; Cui Y; Hou G; Deng J; Gao X; Liao Z; Liu Y; Meng Y; Wu L; Yao C; Wang Y; Qian J; Guo Q; Ding H; Qu B; Shen N
Arthritis Rheumatol; 2018 Dec; 70(12):2036-2045. PubMed ID: 29806091
[TBL] [Abstract][Full Text] [Related]
45. Identification of potential therapeutic drugs targeting core genes for systemic lupus erythematosus (SLE) and coexisting COVID-19: Insights from bioinformatic analyses.
Chen C; Zhang H; Lin Y; Lu M; Liao Q; Zhang S; Chen W; Zheng X; Li Y; Ding R; Wan Z
Immun Inflamm Dis; 2023 Nov; 11(11):e1087. PubMed ID: 38018597
[TBL] [Abstract][Full Text] [Related]
46. Type I interferon gene signature test-low and -high patients with systemic lupus erythematosus have distinct gene expression signatures.
Brohawn PZ; Streicher K; Higgs BW; Morehouse C; Liu H; Illei G; Ranade K
Lupus; 2019 Nov; 28(13):1524-1533. PubMed ID: 31660791
[TBL] [Abstract][Full Text] [Related]
47. Comparative Analysis on Abnormal Methylome of Differentially Expressed Genes and Disease Pathways in the Immune Cells of RA and SLE.
Fang Q; Li T; Chen P; Wu Y; Wang T; Mo L; Ou J; Nandakumar KS
Front Immunol; 2021; 12():668007. PubMed ID: 34079550
[TBL] [Abstract][Full Text] [Related]
48. Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus.
Shen M; Duan C; Xie C; Wang H; Li Z; Li B; Wang T
Front Immunol; 2022; 13():962393. PubMed ID: 35967341
[TBL] [Abstract][Full Text] [Related]
49. Predicted Immune-Related Genes and Subtypes in Systemic Lupus Erythematosus Based on Immune Infiltration Analysis.
Xu L; Su X; Liu Z; Zhou A
Dis Markers; 2022; 2022():8911321. PubMed ID: 35864995
[TBL] [Abstract][Full Text] [Related]
50. Identification of Diagnostic Biomarkers in Systemic Lupus Erythematosus Based on Bioinformatics Analysis and Machine Learning.
Jiang Z; Shao M; Dai X; Pan Z; Liu D
Front Genet; 2022; 13():865559. PubMed ID: 35495164
[TBL] [Abstract][Full Text] [Related]
51. Identification of potential key genes associated with diffuse large B-cell lymphoma based on microarray gene expression profiling.
Luo X; Shi F; Qiu H; Tong Y; Gao X
Neoplasma; 2017; 64(6):824-833. PubMed ID: 28895406
[TBL] [Abstract][Full Text] [Related]
52. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.
Monti S; Savage KJ; Kutok JL; Feuerhake F; Kurtin P; Mihm M; Wu B; Pasqualucci L; Neuberg D; Aguiar RC; Dal Cin P; Ladd C; Pinkus GS; Salles G; Harris NL; Dalla-Favera R; Habermann TM; Aster JC; Golub TR; Shipp MA
Blood; 2005 Mar; 105(5):1851-61. PubMed ID: 15550490
[TBL] [Abstract][Full Text] [Related]
53. Identification of biomarkers related to neutrophils and two molecular subtypes of systemic lupus erythematosus.
Li H; Yang P
BMC Med Genomics; 2022 Jul; 15(1):162. PubMed ID: 35858908
[TBL] [Abstract][Full Text] [Related]
54. Exploring the potential common denominator pathogenesis of system lupus erythematosus with COVID-19 based on comprehensive bioinformatics analysis.
Zeng H; Zhuang Y; Li X; Yin Z; Huang X; Peng H
Front Immunol; 2023; 14():1179664. PubMed ID: 37426642
[TBL] [Abstract][Full Text] [Related]
55. Significance of chromobox protein (CBX) expression in diffuse LBCL.
Hu CY; Li X; Zeng T; Ye DM; Li YK; Yan HX
Gene; 2022 Mar; 813():146092. PubMed ID: 34896523
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of a five-gene signature associated with stromal infiltration for diffuse large B-cell lymphoma.
Nan YY; Zhang WJ; Huang DH; Li QY; Shi Y; Yang T; Liang XP; Xiao CY; Guo BL; Xiang Y
World J Clin Cases; 2021 Jun; 9(18):4585-4598. PubMed ID: 34222425
[TBL] [Abstract][Full Text] [Related]
57. Clinical Values of the Identified Hub Genes in Systemic Lupus Erythematosus.
Xiao L; Zhan F; Lin S
Front Immunol; 2022; 13():844025. PubMed ID: 35757684
[TBL] [Abstract][Full Text] [Related]
58. Role and mechanism of PIM family in the immune microenvironment of diffuse large B cell lymphoma.
Wang C; Chen Q; Luo H; Chen R
World J Surg Oncol; 2023 Mar; 21(1):76. PubMed ID: 36871027
[TBL] [Abstract][Full Text] [Related]
59. Characterization of virus-mediated autoimmunity and the consequences for pathological process in patients with systemic lupus erythematosus.
Kim A; Choi SJ; Song GG; Kim JH; Jung JH
Clin Rheumatol; 2023 Oct; 42(10):2799-2809. PubMed ID: 37369873
[TBL] [Abstract][Full Text] [Related]
60. Integrated analysis of genome‑wide gene expression and DNA methylation microarray of diffuse large B‑cell lymphoma with TET mutations.
Liu P; Jiang W; Zhao J; Zhang H
Mol Med Rep; 2017 Oct; 16(4):3777-3782. PubMed ID: 28731140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
